Does Ohio Medicaid Cover Wegovy or Zepbound?
Ohio (OH) GLP-1 access depends on three state-specific policy questions before it ever gets to pricing: does Ohio Medicaid cover weight-loss GLP-1s, has Ohio expanded Medicaid under the ACA, and does the state employee health plan cover them. Answering those first tells you whether you're likely working with insurance or planning for cash-pay.
Ohio Medicaid GLP-1 coverage: what the state's own documents say
Ohio Medicaid (fee-for-service and all managed care plans, through the single pharmacy benefit manager and Unified PDL) treats drugs for the treatment of obesity as non-covered by rule, covering Wegovy only for reducing cardiovascular events (BMI 27 or higher, prior heart attack, stroke or symptomatic peripheral artery disease, no diabetes) or MASH and Zepbound only for moderate-to-severe sleep apnea (BMI 30 or higher, no diabetes, in-lab sleep study, sleep specialist).
Checked September 20, 2026 against: codes.ohio.gov, spbm.medicaid.ohio.gov, spbm.medicaid.ohio.gov.
Ohio state employee health plan: what the plan's own documents say
Ohio's state employee plan stopped covering weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) on July 1, 2025; its OptumRx drug benefit lists only phentermine and Xenical as covered anti-obesity medications, and diabetes GLP-1s remain covered. The one route to a weight-loss GLP-1 is the Virta weight-loss program (free to plan members with a BMI over 25): a Virta clinician prescribes, the member buys the drug directly from the manufacturer outside the health plan at a reduced price, and only State employees can claim a partial reimbursement of up to $200 of the medication cost, limited to 2,500 employees at a time on a first-come, first-served basis (the State's page showed about 1,740 reimbursements available on July 13, 2026).
Checked October 19, 2026 against: das.ohio.gov, das.ohio.gov, das.ohio.gov, dam.assets.ohio.gov.
Notable insurers active in Ohio (not independently verified): Anthem Blue Cross Blue Shield, Medical Mutual, UnitedHealthcare.
Why GLP-1 coverage varies this much by state
Medicaid is a state-federal partnership, not a single national program. Each state Medicaid agency sets its own preferred drug list (PDL) and prior-authorization criteria within federal minimum requirements. Weight-loss drugs are not a federally mandated Medicaid benefit, so states choose independently whether to cover them - which is why only 10 of 50 states currently do (Ohio is not one of them).
State employee health plans are a useful bellwether. These plans cover hundreds of thousands of state workers and negotiate directly with pharmacy benefit managers, so their coverage decisions often signal where commercial insurers in that state are heading. North Carolina's State Health Plan, for example, ended coverage of weight-loss GLP-1s on April 1, 2024, after its board voted 4-3 to cut it citing the drugs' high cost - a case that other states and large employers have watched closely.
Medicaid expansion status shapes who even has coverage to begin with. States that haven't adopted ACA Medicaid expansion have narrower Medicaid eligibility overall, which - combined with the weight-loss GLP-1 exclusion most states apply regardless of expansion status - pushes a larger share of residents in those states toward commercial insurance, telehealth, or manufacturer self-pay as their only realistic path.
National reference pricing (same nationwide - your actual cost depends on your plan)
These prices are the same across all 50 states because manufacturer list prices, self-pay programs, and telehealth pricing don't vary by state - only insurance coverage and copay do, which is why the Ohio-specific policy facts above matter more than the table below for predicting your actual cost.
| Drug | Covered by insurance | Manufacturer self-pay | Telehealth | Cash retail |
|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $1,349 |
| Ozempic 11.6% weight loss | $63 | - | $399 | $1,028 |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 | $449 | $1,349 |
| Zepbound 22.5% weight loss | $88 | $299 | $499 | $1,059 |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $1,069 |
| Saxenda 8.4% weight loss | $63 | - | $399 | $1,349 |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 | - | $1,099 |
| CagriSema 20.4% weight loss | $88 | $599 | - | $1,499 |
Cheapest cash-pay GLP-1 paths for Ohio residents
Manufacturer direct prices (LillyDirect, NovoCare) are usually cheapest. Updated May 2026.
| Drug | Insurance | Mfr direct | Telehealth (brand) | Telehealth (compd) | Cash retail | Get it |
|---|---|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $249 cheapest | $1,349 | Get →ad |
| Ozempic 11.6% weight loss | $63 | - | $399 | $199 cheapest | $1,028 | Get →ad |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 cheapest | $449 | - | $1,349 | Get →ad |
| Zepbound 22.5% weight loss | $88 | $299 cheapest | $499 | $299 cheapest | $1,059 | Get →ad |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $299 cheapest | $1,069 | Get →ad |
| Saxenda 8.4% weight loss | $63 | - | $399 cheapest | - | $1,349 | Get →ad |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 cheapest | - | - | $1,099 | Get →ad |
Ohio carrier coverage details
National carriers active in Ohio (this list is not independently verified). Drill into each carrier's prior-auth requirements, formulary, and appeal playbook.
Frequently asked questions
Does Ohio Medicaid cover Wegovy or Zepbound for weight loss?
No. Ohio Medicaid (fee-for-service and all managed care plans, through the single pharmacy benefit manager and Unified PDL) treats drugs for the treatment of obesity as non-covered by rule, covering Wegovy only for reducing cardiovascular events (BMI 27 or higher, prior heart attack, stroke or symptomatic peripheral artery disease, no diabetes) or MASH and Zepbound only for moderate-to-severe sleep apnea (BMI 30 or higher, no diabetes, in-lab sleep study, sleep specialist). This was checked against Ohio's own documents on September 20, 2026; coverage rules change often, so confirm with your plan before relying on it. Coverage for type 2 diabetes (Ozempic, Mounjaro) is a separate question. Medicare's GLP-1 Bridge, which started July 1, 2026, works separately from Medicaid and applies in every state.
Has Ohio expanded Medicaid under the ACA?
Yes - Ohio has adopted Medicaid expansion, which broadens who qualifies for Medicaid coverage generally, though it does not by itself guarantee GLP-1 weight-loss coverage (see above).
Does the Ohio state employee health plan cover Wegovy or Zepbound?
Partly. Ohio's state employee plan stopped covering weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) on July 1, 2025; its OptumRx drug benefit lists only phentermine and Xenical as covered anti-obesity medications, and diabetes GLP-1s remain covered. The one route to a weight-loss GLP-1 is the Virta weight-loss program (free to plan members with a BMI over 25): a Virta clinician prescribes, the member buys the drug directly from the manufacturer outside the health plan at a reduced price, and only State employees can claim a partial reimbursement of up to $200 of the medication cost, limited to 2,500 employees at a time on a first-come, first-served basis (the State's page showed about 1,740 reimbursements available on July 13, 2026). This was checked against Ohio's own plan documents on October 19, 2026; plan terms are reset each plan year, so confirm with your plan before relying on it.